Seqalis
Jean-Luc Henrioul is a seasoned professional in the biotech sector with extensive experience in business development and consulting. Currently serving as the Chief Operating Officer at Seqalis since June 2022, Henrioul has also provided freelance consulting services through JLH Consultancy since 2002, assisting biotech start-ups and SMEs. Previous roles include business development positions at Novodiax Inc, Aquality Technologies, and the Medina Foundation, where innovative diagnostic and analytical solutions were developed. Henrioul has a strong educational background, holding a Master in Bioengineering from Gembloux Agro-Bio Tech - Université de Liège and certificates in Molecular and Cellular Biology and Advanced Company Management.
This person is not in any teams
This person is not in any offices
Seqalis
The mission of Seqalis™ is to provide our customers with cutting-edge and high-quality laboratory testing and techniques but also with scientific advisory and research and development services, in Anatomical Pathology, Cytogenomics and Molecular Biology. Seqalis™ collaborates intensively with its mother company, the Institute of Pathology and Genetics (IPG), one of the eight Belgian Genetics Centres, to continuously foster innovation in the medical and diagnostic fields.